Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
Go back to Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service| StemCells, Inc. (NASDAQ: TEM) | Delayed: 62.22 -2.07 (3.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.29 | 52 Week High | $0.45 | |||
| Open | $63.42 | 52 Week Low | $0.37 | |||
| Day High | $64.91 | P/E | N/A | |||
| Day Low | $61.89 | EPS | $-0.31 | |||
| Volume | 1,589,913 | |||||
